-
Survival Statistics 101
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
-
“Congrats! You Have the ‘Good’ Cancer”
Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
-
Learning the Language of Chemotherapy
Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
-
Misunderstandings About Cancer DNA Tests
Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
-
What Not to Say to a Cancer Patient
When visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
Considering the Term “Cancer Survivor”
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
What Do Clinical Trial Endpoints Really Measure?
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
Cancer Talk
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
A Look at Disparities Across Cancer CareA new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
Credit Agencies to Remove Some Medical Debt From ReportsChanges to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.
by Karon Warren
The Mental Toll of a Cancer DiagnosisNew studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
From the AACR
-
Using Lymphocytes to Attack Tumors
Sooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic Testing
Olufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
-
AACR and AACI Collaborate to Advocate for Cancer Research Funding
Federal funding could help cancer centers rebuild from the devastating effects of the pandemic.
Video
Learning Medicare’s ABCDs
